hNSC-01 for Huntington's Disease
(REGEN4HD Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this research study is to determine whether an implantation of hNSC-01 is a safe and tolerable study intervention for Huntington's disease. This study is the first time that hNSC-01 is being tested in people.
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive implantation of hNSC-01 to assess safety and tolerability
Follow-up
Participants are monitored for safety and effectiveness after treatment
Long-term follow-up
Longer term safety assessment including adverse events and various clinical evaluations
What Are the Treatments Tested in This Trial?
Interventions
- hNSC-01
How Is the Trial Designed?
4
Treatment groups
Active Control
Unilateral, low dose
Bilateral, low dose
Bilateral, mid-dose
Bilateral, high dose
Find a Clinic Near You
Who Is Running the Clinical Trial?
Leslie Thompson
Lead Sponsor
California Institute for Regenerative Medicine (CIRM)
Collaborator
University of California, Irvine
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.